Hantavirus Diagnostics Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Hantavirus Diagnostics Market is segmented By Disease Type (Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS)), By Test Technology (Serological Assays, Immunohistochemistry/Immunofluorescence Tests (IHC/IF), Reverse Transcriptase PCR (RT-PCR), Others) By End-User (Hospitals & Clinics, Clinical Diagnostic Labs, Research Institutions, Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Hantavirus Diagnostics Market Size

Global Hantavirus Diagnostics Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031

Hantaviruses are a family of viruses spread mainly by rodents and can cause varied disease syndromes in people worldwide.  Infection with any hantavirus can produce hantavirus disease in people. Each hantavirus serotype has a specific rodent host species and is spread to people via an aerosolized virus that is shed in urine, faeces, and saliva, and less frequently by a bite from an infected host. The most important hantavirus in the United States that can cause HPS is the Sin Nombre virus, spread by the deer mouse.

Hantavirus Diagnostics Market Summary

For more details on this report – Request for Sample

Hantavirus Diagnostics Market Trends

Rise in the prevalence of hantavirus

In humans, Hantaviruses can cause serious fatal diseases such as hemorrhagic fever renal syndrome (HFRS) in Asia, HFRS and nephropathia epidemica (NE) in Europe and Hantavirus cardiopulmonary syndrome (HCPS) in North and South Americas. In recent years, almost 200,000 people around the world have been affected by Hantaviruses annually, with a case fatality of 1–15% for HFRS, 0.1–1% for NE and up to 40–60% for HCPS. 

Two significant outbreaks were documented in the last century which brought the Hantavirus disease to worldwide attention. More than 3,000 United Nations forces contracted the HFRS during the Korean War (1950–1953), which was the first time it happened and the second was the outbreak of HCPS in 1993 in the Four Corners area of the United States.

Furthermore, global hantavirus diagnostics are also driven by various other factors like a rise in the advancements in the therapeutics, novel kit launches by key players and others helping the market to grow during the forecast period.

Complications associated with the disease

Early symptoms include fatigue, fever and muscle aches, especially in the large muscle groups—thighs, hips, back, and sometimes shoulders. These symptoms are universal. There may also be headaches, dizziness, chills, and abdominal problems, such as nausea, vomiting, diarrhea, and abdominal pain. 

Hantavirus Diagnostics Market Segment Analysis

The global hantavirus diagnostics market is segmented based on disease type, test technology, end-user and region.

The hantavirus pulmonary syndrome (HPS) from the disease type segment accounted for approximately 51.7 % of the Hantavirus Diagnostics  market share

The hantavirus pulmonary syndrome (HPS) from the disease type segment accounted for approximately 51.7%. Hantavirus pulmonary syndrome (HPS) is a rare but potentially life-threatening viral illness transmitted to humans from the infected urine, droppings or saliva of certain species of mice and rats. Most cases of HPS in the United States have occurred in the Southwest among people who are exposed to these rodents at their work or home.

For instance, in February 2024, a study in Gyeonggi Province, South Korea, led by Prof. Jin-Won Song, focused on understanding the genomic diversity of Hantaan orthohantavirus (HTNV) and its prevalence, viral loads, and genetic variations. The study used Flongle sequencing, an innovative, cost-efficient, and rapid method, for detecting HTNV genomes.

Hence, the researchers developed a rapid, sensitive on-site diagnostic using a nanopore-based Flongle chip, costing around $100, enabling whole-genome sequencing of HTNV within 3 hours.

Hantavirus Diagnostics Market Geographical Share

North America is estimated to hold about 39.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the factors like rise in the prevalence of hantavirus in the region, collaboration and partnerships, healthcare infrastructure and others that help the region to have the highest market share during the forecast period.

For instance, according to the IDCM factsheet, it is estimated that 100,000 cases of hantavirus occur worldwide each year. HPS is diagnosed sporadically in the United States with cases often occurring in clusters. The largest outbreak occurred in 1993 in the Four Corners area of the Southwest.

Covid 19 Impact Analysis

The COVID-19 pandemic has affected public health investigation and response activities for other illnesses; COVID-19 has particularly challenged the diagnosis of respiratory illnesses because of similar clinical manifestations. Hantavirus pulmonary syndrome is a rare disease transmitted predominantly by infected rodents shedding the virus through saliva, urine, and feces.

Hantavirus Diagnostics Companies

The major global players in the market include Quest Diagnostics Inc., Express Biotech International Inc., LifeSpan BioSciences Inc., Tecan Group Ltd, Aviva Systems Biology LLC, Atlona Diagnostics, Creative Diagnostics, Progen, DRG Diagnostics GmbH and among others.

Why Purchase the Report?

• To visualize the global hantavirus diagnostics market segmentation based on disease type, test technology, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development. 
• Excel data sheet with numerous data points of the hantavirus diagnostics market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global hantavirus diagnostics market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies